Table 1 Patients’ baseline characteristics between the YFJP group and the non-YFJP group
t Variable | YFJP (n = 159) | non-YFJP (n = 318) | p value |
|---|---|---|---|
Age (< 50/ ≥ 50 years) | 32/127 | 75/242 | 0.393 |
Gender (male/female) | 122/37 | 245/73 | 0.939 |
Tumor numbe (Single/Multiple) | 77/82 | 150/168 | 0.795 |
Maximal tumor size (≤ 5/ > 5 cm) | 33/126 | 150/168 |  < 0.001 |
Liver cirrhosis (Yes/No) | 148/11 | 301/17 | 0.491 |
WBC (≤ 4 × 109/l/ > 4 × 109/l) | 85/74 | 201/117 | 0.041 |
RBC (≤ 4 × 109/l/ > 4 × 109/l) | 70/89 | 119/199 | 0.165 |
Platelet (≤ 100 × 109/l/ > 100 × 109/l) | 54/105 | 139/179 | 0.041 |
Serum AFP levels (≥ 400/ < 400 ng/ml) | 50/109 | 127/191 | 0.07 |
TBIL (≥ 18.8 / < 18.8 μmol/l) | 81/78 | 216/102 |  < 0.001 |
ALB (≥ 40 / < 40 g/l) | 38/121 | 56/262 | 0.104 |
ALT (≥ 50 / < 50 U/l) | 40/119 | 113/205 | 0.022 |
AST (≥ 40 / < 40 U/l) | 72/87 | 220/98 |  < 0.001 |
Child stage (Grade A/Grade B/Grade C) | 75/59/25 | 108/133/77 | 0.011 |
NLR (≤ 2.4/ > 2.4) | 66/93 | 119/199 | 0.388 |
BCLC stage (A/B/C/D) | 81/40/12/25 | 53/93/95/77 |  < 0.001 |
Smoking (Yes/No) | 75/84 | 110/208 | 0.008 |
Drinking (Yes/No) | 73/86 | 114/204 | 0.034 |
Diabetes (Yes/No) | 35/124 | 71/247 | 0.938 |
Hypertension (Yes/No) | 52/107 | 76/242 | 0.041 |
γ-GGT (> 60/60 U/l) | 61/98 | 206/112 |  < 0.001 |